A Safe & Natural Alternative
The search for a superior enzyme, one that offered safe but powerful anti-swelling properties, ended when the enzyme Serratia peptidase (Serrapeptase) was discovered in the early 1970’s. It was originally found in the silkworm where it is naturally present in its intestine. Serrapeptase is now widely used throughout Europe and Asia as a viable alternative to salicylates, ibuprofen, and the more potent NSAIDs. Serrapeptase is an anti-swelling, proteolytic enzyme isolated from the micro-organism Serratia E15. This immunologically active enzyme has no inhibitory effects on prostaglandins. It does not have any gastrointestinal side effects, and offers a sensible, safe alternative for those suffering from chronic pain and swelling.
Histology studies reveal the powerful anti-inflammatory effects of this naturally occurring enzyme. The silkworm has a special relationship with the Serratia E15 micro-organisms in its intestines. The enzymes secreted by the bacteria in silkworm intestines have the ability to dissolve non-living tissue, but have no detrimental effect on the host’s living cells. Thus, by dissolving the silkworm’s protective cocoon (non-living tissue), the mature moth is able to emerge.
The blood is not only the river of life, it is also the river through which the cells and organs dispose of their garbage and dead material. The enzymes in Serrapeptase
improve circulation by eating excess fibrin. This excess fibrin can cause blood to get as thick as catsup or yogurt, creating the perfect environment for the formation of clots. All of this material is supposed to be cleaned off by the liver the first time it goes through; however, given the sluggish and near toxic state of everyone’s liver these days, that seldom happens. So, the sludge remains in the blood, waiting for the liver to have enough free working space and enough enzymes to clean the trash out of the blood. This can take days, and for some people, even weeks! The enzymes in Serrapeptase help
take the strain off of the liver by:
- cleaning excess fibrin from the blood and reducing the stickiness of blood cells, thereby minimizing the the leading causes of stroke and heart attack... blood clots.
- breaking dead material down small enough that it can immediately pass into the bowel.
Hans A. Nieper, M.D., an internist from Hannover, Germany, studied the effects of Serrapeptase
on plaque accumulations in the arteries. The formation of plaque involves deposits of fatty substances, cholesterol, cellular waste products, calcium and fibrin (a clotting material in the blood) on the inner lining of the arteries. Excessive plaque results in partial or complete blockage of the blood's flow through an artery, resulting in arteriosclerosis, or hardening of the arteries, and an ensuing stroke or heart attack. Nieper's research indicated that the protein-dissolving action of Serrapeptase
will gradually break down atherosclerotic plaques.
Carpal Tunnel Syndrome (CTS)
In 1999, a study was conducted to assess how patients suffering from CTS would respond to treatment with Serrapeptase. After six weeks, 65% of the participants showed a significant improvement. This was supported by electrophysiological parameters taken before and after the study. Such results would indicate that Serrapeptase may indeed be an effective, safe treatment for people dealing with CTS.